KVUE

$19.99 0.33 (1.62%)

19:00 EDT KVUE Stock Quote Delayed 30 Minutes

KVUE Stock Alert: Johnson & Johnson Reveals Results of Kenvue Exchange Offer

By Josh Enomoto, InvestorPlace Contributor Aug 21, 2023

Johnson & Johnson revealed that its share exchange offer with Kenvue was oversubscribed, leading to beneficial trading for KVUE stock.

KVUE Stock Alert: Kenvue to Join the S&P 500

Is Johnson & Johnson Giving Up on Kenvue (KVUE) Stock?

3 Healthcare Stocks to Buy as the Market Gets Defensive

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 25.25M

Day's Range $19.91 - $20.59

52-Week Range $19.95 - $27.03

Dividend & Yield $0.20 (1.00%)

KVUE Stock Predictions, Articles, and News

From InvestorPlace
From the Web

7 Up-and-Coming Stocks to Buy for the Next Decade

By Josh Enomoto, InvestorPlace Contributor Jun 29, 2023

While less-established enterprises are best left for speculators, these up-and-coming stocks to buy also feature huge upside potential.

7 Consumer Stocks to Buy and Hold for the Long Haul

By Thomas Niel, InvestorPlace Contributor May 29, 2023

So, what are some of the best long-term consumer stocks to buy today? Consider these seven. All of them are attractively-priced at present, and each one offers the potential to provide satisfactory returns over a multi-year timeframe.

SLRN Stock IPO: When Does Acelyrin Go Public? What Is the Acelyrin IPO Price Range?

By Chris MacDonald, InvestorPlace Contributor May 4, 2023

Here's what prospective investors in Acelyrin and SLRN stock may want to watch out for as the company gears up for its IPO.

KVUE Stock Alert: 10 Things to Know as Kenvue Starts Trading

By William White, InvestorPlace Writer May 4, 2023

Kenvue (KVUE) stock is set to start trading on Thursday as the company completes its spinoff from Johnson & Johnson (JNJ).

KVUE Stock: Should You Buy Into the Kenvue IPO?

By Dana Blankenhorn, InvestorPlace Contributor May 3, 2023

KVUE stock will be a dividend stock with an initial yield of 3.5%, with slow growth and lower margins than JNJ's drug business.

KVUE Stock IPO: When Does Kenvue Go Public? What Is the Kenvue IPO Price Range?

By Samuel O'Brient, InvestorPlace Financial News Writer May 1, 2023

Johnson & Johnson spinoff Kenvue is gearing up to go public on May 4. Here's what investors need to know about KVUE stock and the Kenvue IPO.

2 Exceptional Dividend Stocks to Buy in October and Hold Forever

From The Motley Fool Oct 1, 2023

Temporary challenges are creating bargain opportunities for investors with a long-term mindset.

Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?

From The Motley Fool Oct 1, 2023

Kenvue says rewarding shareholders is an important part of its strategy.

Is Kenvue Stock Too Pricey to Buy?

From The Motley Fool Sep 30, 2023

Its valuation depends on its brands being highly valuable indefinitely.

A Bull Market Is Coming: 3 Top Dividend Stocks to Buy Now

From The Motley Fool Sep 29, 2023

These steadfast investments can help you earn more passive income.

3 Things About Johnson & Johnson That Smart Investors Know

From The Motley Fool Sep 27, 2023

J&J shares have missed out on the market rally so far this year.

3 Best Stocks to Buy in September and Hold Forever

From The Motley Fool Sep 24, 2023

Healthcare blue chip stocks with proven track records can be excellent long-term investments.

KVUE

KVUE Stock Alert: Johnson & Johnson Reveals Results of Kenvue Exchange Offer

KVUE Stock Alert: Kenvue to Join the S&P 500

Is Johnson & Johnson Giving Up on Kenvue (KVUE) Stock?

3 Healthcare Stocks to Buy as the Market Gets Defensive

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

KVUE

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

KVUE Stock Predictions, Articles, and News

Subscriber Sign in